As evidence continues to mount that establishes a link between Actos and bladder cancer, the FDA is taking steps to make sure that consumers and the medical community are aware of the potential risk. However, it appears that Takeda Pharmaceuticals knew or should have known this… Read More
France has suspended sales of Actos, a popular diabetes drug that has been linked to a possible risk of bladder cancer. The recall comes after a number of studies, leading some to question why an Actos recall has not been issued in the United States. >>MORE… Read More
A recent study has detected an unusually high number of reports of bladder cancer that appear to be linked to the diabetes drug Actos. The lawyers at Saiontz & Kirk, P.A. are reviewing potential Actos lawsuits for individuals diagnosed with bladder cancer to determine whether financial… Read More
